HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD Has ‘High Hopes’ Firms Will Cooperate On Schedules To Accelerate Reviews

This article was originally published in The Rose Sheet

Executive Summary

The National Advertising Division changes its review process to allow opposing companies greater control over scheduling and resolving their disputes. The changes, recommended by ABA committees, also impose fees on both firms in appeals and allow more time for compliance with decisions.

You may also be interested in...



NAD Fed Up With ‘Confidentiality’ Cop-Outs; Are Advertisers ‘Hiding The Ball’?

The National Advertising Division is weary of companies claiming confidentiality in its dispute resolution forum without adequately detailed cause or earnest efforts to meet the option’s requirements. A panel at the group’s annual meeting discussed the issue and steps advertisers should take to protect their competitive interests without compromising themselves or the self-regulatory system.

Flonase Ad Claims Settlement Confidential, But McNeil Likely Gains Choosing Court Over NAD

When prompt action is a primary goal, as McNeil aimed for in challenging ad claims for Glaxo’s Flonase Allergy Relief, lawyers say going to court is a better option than going to the National Advertising Division. Even with allegations that wither under the opposing firm’s rebuttal, litigation of advertising complaints it gains publicity than a NAD review would generate.

Final Quarter Of P&G CEO Taylor’s Tenure Could Become Stormy With Headwinds From Rising Costs

P&G’s health care sector’s net sales grew 18% in its latest quarter. Continued growth across its sectors is critical in the face of expected $1.8bn in headwinds from commodity and freight costs in its FY2022.

UsernamePublicRestriction

Register

RS019686

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel